CDMO Business

Our dedicated facilities and quality system are satisfied with cGMP standards and have been proved by several inspections from USFDA, EDQM, PMDA and KFDA.

Since Kyongbo’s establishment in 1987, with many years of experience in manufacturing a wide range of APIs in terms of batch size, and classification, Kyongbo has become a top API manufacturer in Korea.

Currently, 7 API plants are running at Kyongbo site. Kyongbo has accumulated intensive expertise and experience in API processes required to fulfill CRMO projects from pre-clinical up to Clinical trials phase Ⅰ,Ⅱ,Ⅲ.

Skilled staffs with sufficient experiences from CRMO Business Unit (CBU) in Kyongbo are set up to focus on the project and expand the business abroad which will facilitate the close communication and speedy response with the clients.

Wide range of manufacturing facilities and analytical instruments (NMR, XRD, FT-IR, UV-Vis, LC (GC)-mass, ICP, DSC, TGA, PSD, SEM, Electron Microscope, and etc) are available so we are capable of developing the process, identification & isolation of impurities.